Aldeyra Therapeutics (ALDX) Tops Q3 EPS by 9c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.25), $0.09 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• William Blair Upgrades Backblaze Inc (BLZE) to Market Perform